Impaired Decision-making in Adolescents
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01253993|
Recruitment Status : Completed
First Posted : December 6, 2010
Last Update Posted : December 6, 2010
|Condition or disease|
|Adolescent Psychiatry Antisocial Personality Disorders Substance-Related Disorders|
This study consists of two substudies with adolescents in the age of 14-21 years. The first study group consist of adolescents with DBD with (n=30) and without (n=30) substance use disorders. These adolescents are recruited from orthopsychiatric, forensic psychiatric, and judicial institutions.
The second study group consists of a) ex-patients of the Utrecht Coping Power Program (UCPP)who previously participated to a follow-up study, and b) ex-patients who were treated as a child at an outpatient clinic of the UMC Utrecht. These latter groups were taken together and subdivided into a group with (n=30) and without (n=30) substance use problems.
For both studies healthy controls (n=80) are recruited. The investigators will start with healthy controls from earlier studies, and those are extented and will serve as control group for both studies.
|Study Type :||Observational|
|Actual Enrollment :||152 participants|
|Observational Model:||Case Control|
|Official Title:||Impaired Decision-making in Adolescents: A Vulnerability Factor for the Development of Substance Use and Abuse.|
|Study Start Date :||April 2006|
|Actual Primary Completion Date :||June 2007|
|Actual Study Completion Date :||September 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01253993
|University Medical Center Utrecht|
|Utrecht, Netherlands, 3584 CX|
|Principal Investigator:||Walter Matthys, MD, PhD||UMC Utrecht|